Page last updated: 2024-08-16

rivastigmine and Autosomal Dominant Juvenile Parkinson Disease

rivastigmine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damier, P; Meyniel, C1
Clerici, F; Elia, A; Maggiore, L; Mariani, C; Pomati, S; Ratti, PL1
Butler, S; Byrne, EJ; Daniel, S; Grace, J; McKeith, IG; Shankar, KK; Stevens, T; Waite, J; Walker, Z; Wilkinson, D; Woolford, J1

Reviews

1 review(s) available for rivastigmine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
[Lewy body dementia and Parkinson disease dementia].
    Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:10 Pt 2

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Dementia; Diagnosis, Differential; Disease Progression; Dopamine Agents; Humans; Iatrogenic Disease; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Parkinsonian Disorders; Phenylcarbamates; Psychotropic Drugs; Rivastigmine; Serotonin Antagonists

2007

Trials

1 trial(s) available for rivastigmine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
    International psychogeriatrics, 2001, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neuroprotective Agents; Parkinsonian Disorders; Phenylcarbamates; Rivastigmine; Treatment Outcome

2001

Other Studies

1 other study(ies) available for rivastigmine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Cholinergic balance in dementia with Lewy bodies: reversible worsening of Parkinsonism at rivastigmine dosage modulation.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2007, Volume: 28, Issue:5

    Topics: Acetylcholine; Aged; Cholinesterase Inhibitors; Disease Progression; Humans; Lewy Body Disease; Male; Parkinsonian Disorders; Phenylcarbamates; Rivastigmine; Time Factors

2007